Holen Sie sich die Stockscreener-App
122.97
0.10%
0.12
Schlusskurs vom Vortag:
$122.85
Offen:
$122.85
24-Stunden-Volumen:
1.40M
Relative Volume:
2.21
Marktkapitalisierung:
$7.43B
Einnahmen:
$3.99B
Nettoeinkommen (Verlust:
$463.16M
KGV:
-78.32
EPS:
-1.57
Netto-Cashflow:
$1.10B
1W Leistung:
-0.06%
1M Leistung:
+3.13%
6M Leistung:
+14.54%
1J Leistung:
+2.71%
1-Tages-Spanne:
$121.37
$124.39
1-Wochen-Bereich:
$119.14
$126.23
52-Wochen-Spanne:
$99.06
$134.17
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
Firmenname
Jazz Pharmaceuticals Plc
Sektor
Branche
Telefon
353-1-634-7800
Adresse
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Vergleichen Sie JAZZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
122.97 | 7.43B | 3.99B | 463.16M | 1.10B | 7.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | Eingeleitet | Goldman | Buy |
| 2024-01-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-11-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-06-12 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2022-12-09 | Hochstufung | Goldman | Neutral → Buy |
| 2022-06-14 | Eingeleitet | UBS | Buy |
| 2022-04-06 | Herabstufung | Goldman | Buy → Neutral |
| 2021-11-19 | Fortgesetzt | Goldman | Buy |
| 2021-10-07 | Fortgesetzt | Jefferies | Buy |
| 2021-10-05 | Eingeleitet | Citigroup | Buy |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-05-19 | Fortgesetzt | JP Morgan | Overweight |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-02-05 | Bestätigt | H.C. Wainwright | Buy |
| 2021-02-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-11-03 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-14 | Herabstufung | Goldman | Neutral → Sell |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | Eingeleitet | Jefferies | Buy |
| 2020-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | Eingeleitet | Goldman | Neutral |
| 2019-08-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2018-12-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2018-11-08 | Bestätigt | B. Riley FBR | Buy |
| 2018-08-08 | Bestätigt | Stifel | Buy |
| 2018-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | Bestätigt | H.C. Wainwright | Neutral |
| 2018-03-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten
Sanctuary Advisors LLC Buys 9,804 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Akari Therapeutics Names Interim CEO Patel as Permanent Chief, Adds Jazz Pharma Veteran to Board - StockTitan
Jazz Pharmaceuticals CEO to retire by end 2025, search begins - Investing.com Australia
Public Employees Retirement System of Ohio Makes New $2.49 Million Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals CEO to Present Strategic Vision at JP Morgan Healthcare Conference 2025 - StockTitan
Big Peninsula drugmaker on the hunt for new CEO - The Business Journals
Jazz Pharmaceuticals CEO to Retire, Succession Search Underway - Sleep Review
Graft-Versus-Host Disease Market on Track for Major Expansion - openPR
Jazz Pharmaceuticals Announces CEO Succession Plan - PharmiWeb.com
Jazz Pharmaceuticals CEO to retire - MSN
Bruce Cozadd to retire as Jazz’s CEO - BioCentury
Bruce Cozadd to Retire as Chief Executive Officer of Jazz Pharmaceuticals plc Upon Appointment of Successor by the End of 2025 - Marketscreener.com
Jazz Pharmaceuticals CEO to retire by end of 2025 - Investing.com South Africa
Jazz to search for new chief as CEO plans retirement - BioPharma Dive
Jazz Pharmaceuticals CEO to Step Down After Two Decades of Transformative Leadership - StockTitan
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock Position Raised by Franklin Resources Inc. - MarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Teachers Retirement System of The State of Kentucky - MarketBeat
Is Now The Time To Put Jazz Pharmaceuticals (NASDAQ:JAZZ) On Your Watchlist? - Yahoo Finance
Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch - Yahoo Finance
Morgan Stanley boosts Jazz Pharmaceuticals stock rating, sees upside with Ziihera launch - Investing.com Nigeria
Jazz Pharmaceuticals retains stock target, Overweight rating on FDA approval By Investing.com - Investing.com Nigeria
Morgan Stanley upgrades Jazz Pharmaceuticals shares, highlights Ziihera’s growth potential - Investing.com Nigeria
Morgan Stanley Upgrades Jazz Pharmaceuticals (NASDAQ:JAZZ) to "Overweight" - MarketBeat
Needham & Company LLC Reaffirms "Buy" Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ) - MarketBeat
State Street Corp Sells 71,036 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Y Intercept Hong Kong Ltd Reduces Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Stifel Financial Corp Has $15.83 Million Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Jane Street Group LLC - MarketBeat
Jazz Pharmaceuticals Showcases Evidence Reinforcing Epidiolex (CBD) Medical Benefits - Cannabis Business Times
Two Sigma Advisers LP Purchases 84,500 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
CBD Drug For Tuberous Sclerosis: Caregivers Continue Epidiolex Treatment Citing Seizure Reduction And Cognitive Improvements - Benzinga
XTX Topco Ltd Grows Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Price Target at $175.33 - MarketBeat
BNP Paribas Financial Markets Lowers Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Quantinno Capital Management LP Boosts Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Celebrating International Volunteers Day: Honoring the Impa - CSRwire.com
Jazz Pharma's Epidiolex Shows Remarkable 87% Seizure Reduction in Real-World Epilepsy Studies - StockTitan
Jazz (JAZZ) Up 3.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Point72 Asset Management L.P. Acquires 86,768 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Fmr LLC Reduces Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Bank of Montreal Can Sells 49,214 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Insider Sell: Bruce Cozadd Sells 2,000 Shares of Jazz Pharmaceuticals PLC - GuruFocus.com
Jazz Pharma's Groundbreaking Cancer Drug Ziihera Secures NCCN Guidelines Recognition After FDA Approval - StockTitan
Systematic Financial Management LP Purchases 29,647 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Centiva Capital LP - MarketBeat
Jazz Pharmaceuticals' chief accounting officer sells $6,491 in shares By Investing.com - Investing.com Nigeria
Jazz Pharmaceuticals CEO Bruce Cozadd sells $242,340 in shares By Investing.com - Investing.com Canada
Jazz Pharmaceuticals CEO Bruce Cozadd sells $242,340 in shares - Investing.com
Jazz Pharmaceuticals to Showcase Breakthrough Cancer Drug Ziihera Following FDA Approval - StockTitan
Parkman Healthcare Partners LLC Purchases New Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
Jazz Pharmaceuticals Plc-Aktie (JAZZ) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Carr Patricia | SVP, Chief Accounting Officer |
Dec 02 '24 |
Sale |
122.49 |
53 |
6,492 |
6,596 |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):